参考文献/References:
[1] 王 玲.CEA、NSE、CYFRA21-1、Pro GRP联合检测在肺癌诊断中的临床研究[J].临床检验杂志:电子版,2020,9(1):186-187.
[2] 曹毛毛,陈万青.中国恶性肿瘤流行情况及防控现状[J].中国肿瘤临床,2019,46(3):145-149.
[3] 石远凯,孙 燕,于金明,等.中国晚期原发性肺癌诊治专家共识[J].中国肺癌杂志,2016,19(1):1-15.
[4] 北京医学奖励基金会肺癌青年专家委员会,中国胸外科肺癌联盟.肺癌骨转移诊疗专家共识[J].中国肺癌杂志,2019,22(4):187-207.
[5] 孔 学,贾英杰,刘宏根.中药联合唑来膦酸治疗肺癌骨转移的系统评价[J].世界科学技术-中医药现代化,2018,20(11):1936-1942.
[6] 肖培根.新编中药志[M].北京:化学工业出版社,2000:100-104.
[7] 赵 惠,王志英,周仲瑛.周仲瑛从痰辨治恶性肿瘤用药分析[J].中医杂志,2015,56(9):740-744.
[8] 何泽源,张妍妍,郭海姣,等.王不留行质量标志物预测分析[J].辽宁中医药大学学报,2020,22(3):87-96.
[9] 程 霜,邹丽珺,陈滨海,等.陈卫建诊治恶性肿瘤经验介绍[J].新中医,2020,52(20):178-181.
[10] 江啸锋,张海波,陈惠惠.刘伟胜辨治肺癌骨转移经验[J].山东中医杂志,2019,38(8):774-777,786.
[11] 吴志强,蔡鹏涛,潘方舒,等.肺癌骨转移中医药治疗研究现状[J].陕西中医药大学学报,2016,39(2):103-106.
[12] Chang JH,Lai SL,Chen WS,et al.Quercetin suppresses the metastatic ability of lung cancer through inhibiting snail-dependent akt activation and snail-independent ADAM9 expression pathways[J].Biochimica et Biophysica Acta,2017,1864(10):1746-1758.
[13] 周玲玉.β-谷甾醇对人肺癌细胞增殖、凋亡影响的初步研究[D].重庆:重庆医科大学,2016.
[14] Woyengo TA,Ramprasath VR,Jones JH.Anticancer effects of phytosterols[J].European Journal of Clinical Nutrition,2009,63(7):813-820.
[15] Yebei Q,Xiaocheng C,Lihua L,et al.Modulation of mnsod and foxm1 is involved in invasion and emt suppression by isovitexin in hepatocellular carcinoma cells[J].Cancer Management and Research,2020,20(14):5759-5771.
[16] Qi LS,Li TH,Shi G,et al.An individualized gene expression signature for prediction of lung adenocarcinoma metastases[J].Molecular Oncology,2017,11(11):1630-1645.
[17] Shakya R,Tarulli GA,Sheng L,et al.Mutant p53 upregulates alpha-1 antitrypsin expression and promotes invasion in lung cancer[J].Oncogene,2017,36(31):4469-4480.
[18] Yeudall W,Andrew A,Vaughan J,et al.Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration[J].Medicine,2012,33(2):442-451.
[19] Wassim AK,Paul GH,Philip M,et al.Self-renewing Pten-/- TP53-/- protospheres produce metastatic adenocarcinoma cell lines with multipotent progenitor activity[J].PLoS One,2017,6(10):261-262.
[20] Koh F,Yoichiro M,Toshiki I,et al.Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292[J].Clinical & Experimental Metastasis,2011,28(7):649-659.
[21] Annette K,Larsen D,Ouaret K,et al.Targeting EGFR and VEGF(R)pathway cross-talk in tumor survival and angiogenesis[J].Pharmacology and Therapeutics,2011,131(1):88-90.
[22] 罗继文,陈光明,岑小波.miR-1靶向调控VEGFA肺癌干细胞侵袭和转移的影响[J].中国免疫学杂志,2020,36(10):1240-1245.
[23] Khatlani TS,Wislez M,Sun M,et al.C-jun N-terminal kinase is activated in non-small-cell lung cancer and promotes neoplastic transformation in human bronchial epithelial cells[J].Oncogene,2007,26(18):2658-2666.
[24] Joo HE,Lee HJ,Shin E,et al.C-jun N-terminal Kinase-dependent endoplasmic reticulum stress pathway is critically involved in arjunic acid induced apoptosis in non-small cell lung cancer cells[J].Phytotherapy Research:PTR,2016,30(4):596-603.
[25] Takahashi O,Komaki R,Smith PD,et al.Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis growth and metastasis[J].Clinical Cancer Research,2012,18(6):1641-1654.
[26] 李耀杰,汤素娜,王保收,等.miR-105-5p靶向MAPK1抑制非小细胞肺癌细胞A549的生长、运动和上皮间质转化[J].中国免疫学杂志,2020,36(20):2485-2490.
[27] Kameda T,Dobashi H.Rheumatoid arthritis and malignancy[J].Nihon Rinsho,2016,74(6):1017-1021.
[28] Hideki S,Shinsuke T,Kenji M,et al.A cytokine signal inhibitor for rheumatoid arthritis enhances cancermetastasis via depletion of NK cells in an experimental lung metastasis mousemodel of colon cancer[J].Oncology Letters,2017,14(3):3019-3027.
[29] 范秋灵,李卅立,蒲 实,等.多配体蛋白聚糖-4是糖尿病肾病的候选基因[J].中华肾脏病杂志,2012,28(4):312-317.
[30] 方 洁,宋建星,吴 媚.多配体蛋白聚糖-4在瘢痕疙瘩中的表达[J].中国老年学杂志,2008,28(21):2127-2128.
[31] 黄 珊,宁佐伟,王国正,等.脂多糖通过NOD样受体蛋白3炎症小体通路诱导大鼠急性肝损伤实验研究[J].陕西医学杂志,2021,50(3):264-267,271.
相似文献/References:
[1]刘海涛 ,衣秀秀,田建辉△.肺癌中西医抗凝治疗研究进展*[J].陕西中医,2020,(1):127.
[2]邵翠丽,周晋华△,杨勤军,等.周晋华运用环磷酰胺联合中药紫杉治疗晚期肺癌经验*[J].陕西中医,2020,(2):223.
SHAO Cuili,ZHOU Jinhua,YANG Qinjun,et al.ZHOU Jinhua treats advanced lung cancer with cyclophosphamide and purple shirt[J].,2020,(9):223.
[3]汪 莉,杜红旭,周正国,等.攻癌固真汤联合吉非替尼治疗肺癌气虚血瘀证疗效及对患者血流状态的影响[J].陕西中医,2021,(3):338.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
WANG Li,DU Hongxu,ZHOU Zhengguo,et al.Clinical effect of Gong'ai Guzhen decoction combined with gefitinib in treating lung cancer with Qixu Xueyu syndrome and affect blood flow state[J].,2021,(9):338.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.017]
[4]郑 茜,刘远婷,丁甜甜,等.消积抑癌方对Lewis肺癌荷瘤小鼠MMP-2的影响[J].陕西中医,2021,(7):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
ZHENG Qian,LIU Yuanting,DING Tiantian,et al.Effect of Xiaoji Yi'ai recipe on MMP-2 in Lewis lung cancer bearing mice[J].,2021,(9):844.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.007]
[5]杨 昕,李和根.肺癌辨证分型研究进展[J].陕西中医,2021,(9):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
YANG Xin,LI Hegen.Progress in syndrome differentiation of lung cancer[J].,2021,(9):1313.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.043]
[6]简小兰,蒋益兰,蒋盛昶.蒋益兰教授治疗恶性肿瘤骨转移经验[J].陕西中医,2022,(5):620.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.018]
JIAN Xiaolan,JIANG Yilan,JIANG Shengchang.Experiences from Professor JIANG Yilan in treating bone metastasis of malignant tumour[J].,2022,(9):620.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.018]
[7]李 健,贾 瑞,王 超,等.健脾益气汤联合化疗对肺癌术后患者免疫功能的影响[J].陕西中医,2023,(4):459.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.011]
LI Jian,JIA Rui,WANG Chao,et al.Effect of Jianpi Yiqi decoction combined with chemotherapy on immune function in patients with lung cancer after surgery[J].,2023,(9):459.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.011]
[8]宁永波,王雅兴,陈香颖,等.名中医王瑞平“期证相合”理论在肺癌术后研究肿瘤微环境经验[J].陕西中医,2023,(10):1448.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.026]
NING Yongbo,WANG Yaxing,CHEN Xiangying,et al.Wang Ruiping's theory of “phase correspondence” in postoperative lung cancer patients[J].,2023,(9):1448.[doi:DOI:10.3969/j.issn.1000-7369.2023.10.026]
[9]张 尤,陈 炜.名中医韩明向基于“一本四证”论治肺癌经验[J].陕西中医,2023,(12):1788.[doi:DOI:10.3969/j.issn.1000-7369.2023.12.027]
[10]陈香颖,宁永波,王雅兴,等.名中医王瑞平运用“培土生金法”治疗肺癌经验[J].陕西中医,2024,(4):536.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.023]
CHEN Xiangying,NING Yongbo,WANG Yaxing,et al.Experience of professor Wang Ruiping using “tonifying the spleen and replenishing the lung” to treat lung cancer[J].,2024,(9):536.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.023]